VivoSim Labs, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
VivoSim Labs, Inc. (VIVS) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 8.70 million shares for the 12-month period ending 2022-03-31, per its 10-K filed 2022-06-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-06-10
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 8.71M shares, a 13.76% increase year-over-year.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 8.71M shares, a 26.92% increase year-over-year.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 8.71M shares, a 32.60% increase year-over-year.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 8.70M shares, a 33.19% increase year-over-year.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2022 was 8.70M shares, a 26.10% increase from fiscal 2021.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 6.90M shares, a 6.55% increase from fiscal 2020.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 6.48M shares, a 94.39% decline from fiscal 2019.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 115.38M shares, a 7.59% increase from fiscal 2018.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 8.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | 8.71M shares derived: average of 2 quarters · filed 2022-06-10 | 8.71M shares derived: average of 3 quarters · filed 2022-06-10 | 8.70M shares 10-K · filed 2022-06-10 | ||||
| 2021-12-31 | 8.71M shares 10-Q · filed 2022-02-14 | 8.71M shares derived: average of 2 quarters · filed 2022-02-14 | 8.70M shares 10-Q · filed 2022-02-14 | 8.44M shares derived: average of 4 quarters · filed 2022-06-10 | ||||
| 2021-09-30 | 8.71M shares 10-Q · filed 2021-11-08 | 8.70M shares 10-Q · filed 2021-11-08 | 8.35M shares derived: average of 3 quarters · filed 2022-06-10 | 7.98M shares derived: average of 4 quarters · filed 2022-06-10 | ||||
| 2021-06-30 | 8.70M shares 10-Q · filed 2021-08-06 | 8.17M shares derived: average of 2 quarters · filed 2022-06-10 | 7.74M shares derived: average of 3 quarters · filed 2022-06-10 | 7.44M shares derived: average of 4 quarters · filed 2022-06-10 | ||||
| 2021-03-31 | 7.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | 7.26M shares derived: average of 2 quarters · filed 2022-06-10 | 7.03M shares derived: average of 3 quarters · filed 2022-06-10 | 6.90M shares 10-K · filed 2022-06-10 | ||||
| 2020-12-31 | 6.86M shares 10-Q · filed 2022-02-14 | 6.71M shares derived: average of 2 quarters · filed 2022-02-14 | 6.65M shares 10-Q · filed 2022-02-14 | 6.62M shares derived: average of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | 6.57M shares 10-Q · filed 2021-11-08 | 6.55M shares 10-Q · filed 2021-11-08 | 6.54M shares derived: average of 3 quarters · filed 2021-11-08 | 6.54M shares derived: average of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | 6.53M shares 10-Q · filed 2021-08-06 | 130.59M shares 10-Q · filed 2020-08-10 | 6.53M shares derived: average of 2 quarters · filed 2021-08-06 | 6.53M shares derived: average of 3 quarters · filed 2021-08-06 | 6.52M shares derived: average of 4 quarters · filed 2021-08-06 | |||
| 2020-03-31 | 6.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | 6.52M shares derived: average of 2 quarters · filed 2021-06-15 | 6.52M shares derived: average of 3 quarters · filed 2021-06-15 | 6.48M shares 10-K · filed 2021-06-15 | 129.56M shares 10-K · filed 2020-05-28 | |||
| 2019-12-31 | 6.52M shares 10-Q · filed 2021-02-08 | 130.47M shares 10-Q · filed 2020-02-10 | 6.52M shares derived: average of 2 quarters · filed 2021-02-08 | 6.46M shares 10-Q · filed 2021-02-08 | 129.23M shares 10-Q · filed 2020-02-10 | 64.86M shares derived: average of 4 quarters · filed 2021-02-08 | ||
| 2019-09-30 | 6.52M shares 10-Q · filed 2020-11-05 | 130.36M shares 10-Q · filed 2019-11-07 | 6.43M shares 10-Q · filed 2020-11-05 | 128.62M shares 10-Q · filed 2019-11-07 | 84.31M shares derived: average of 3 quarters · filed 2020-11-05 | 92.29M shares derived: average of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | 126.85M shares 10-Q · filed 2020-08-10 | 123.20M shares derived: average of 2 quarters · filed 2020-08-10 | 120.89M shares derived: average of 3 quarters · filed 2020-08-10 | 119.16M shares derived: average of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | 119.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | 117.90M shares derived: average of 2 quarters · filed 2020-05-28 | 116.60M shares derived: average of 3 quarters · filed 2020-05-28 | 115.38M shares 10-K · filed 2020-05-28 | ||||
| 2018-12-31 | 116.26M shares 10-Q · filed 2020-02-10 | 115.12M shares derived: average of 2 quarters · filed 2020-02-10 | 113.99M shares 10-Q · filed 2020-02-10 | 113.10M shares derived: average of 4 quarters · filed 2020-02-10 | ||||
| 2018-09-30 | 113.99M shares 10-Q · filed 2019-11-07 | 112.73M shares 10-Q · filed 2019-11-07 | 112.05M shares derived: average of 3 quarters · filed 2019-11-07 | 110.87M shares derived: average of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | 111.46M shares 10-Q · filed 2019-08-08 | 111.07M shares derived: average of 2 quarters · filed 2019-08-08 | 109.83M shares derived: average of 3 quarters · filed 2019-08-08 | 108.95M shares derived: average of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | 110.69M shares 10-K · filed 2018-05-31 | 109.02M shares derived: average of 2 quarters · filed 2019-02-07 | 108.11M shares derived: average of 3 quarters · filed 2019-02-07 | 107.24M shares 10-K · filed 2019-06-03 | ||||
| 2017-12-31 | 107.35M shares 10-Q · filed 2019-02-07 | 106.82M shares derived: average of 2 quarters · filed 2019-02-07 | 106.11M shares 10-Q · filed 2019-02-07 | 105.68M shares derived: average of 4 quarters · filed 2019-02-07 | ||||
| 2017-09-30 | 106.30M shares 10-Q · filed 2018-11-08 | 105.50M shares 10-Q · filed 2018-11-08 | 105.12M shares derived: average of 3 quarters · filed 2018-11-08 | 104.14M shares derived: average of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | 104.69M shares 10-Q · filed 2018-08-09 | 104.54M shares derived: average of 2 quarters · filed 2018-08-09 | 103.42M shares derived: average of 3 quarters · filed 2018-08-09 | 100.86M shares derived: average of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | 104.39M shares 10-K · filed 2018-05-31 | 102.78M shares derived: average of 2 quarters · filed 2018-05-31 | 99.58M shares derived: average of 3 quarters · filed 2018-05-31 | 97.76M shares 10-K · filed 2018-05-31 | ||||
| 2016-12-31 | 101.17M shares 10-K · filed 2018-05-31 | 97.18M shares derived: average of 2 quarters · filed 2018-05-31 | 95.60M shares 10-Q · filed 2018-02-08 | 94.79M shares derived: average of 4 quarters · filed 2018-05-31 | ||||
| 2016-09-30 | 93.19M shares 10-K · filed 2018-05-31 | 92.79M shares 10-Q · filed 2017-11-09 | 92.66M shares derived: average of 3 quarters · filed 2018-05-31 | 92.59M shares derived: average of 4 quarters · filed 2018-05-31 | ||||
| 2016-06-30 | 92.39M shares 10-K · filed 2018-05-31 | 92.40M shares derived: average of 2 quarters · filed 2018-05-31 | 92.40M shares derived: average of 3 quarters · filed 2018-05-31 | 92.39M shares derived: average of 4 quarters · filed 2018-05-31 | ||||
| 2016-03-31 | 92.40M shares 10-K · filed 2017-06-07 | 92.40M shares derived: average of 2 quarters · filed 2017-06-07 | 92.39M shares derived: average of 3 quarters · filed 2017-06-07 | 90.06M shares 10-K · filed 2018-05-31 | ||||
| 2015-12-31 | 92.40M shares 10-K · filed 2017-06-07 | 92.39M shares derived: average of 2 quarters · filed 2017-06-07 | 90.03M shares 10-Q · filed 2017-02-09 | 87.18M shares derived: average of 4 quarters · filed 2017-06-07 | ||||
| 2015-09-30 | 92.39M shares 10-K · filed 2017-06-07 | 87.72M shares 10-Q · filed 2016-11-03 | 85.44M shares derived: average of 3 quarters · filed 2017-06-07 | 84.20M shares derived: average of 4 quarters · filed 2017-06-07 | ||||
| 2015-06-30 | 82.99M shares 10-K · filed 2017-06-07 | 81.97M shares derived: average of 2 quarters · filed 2017-06-07 | 81.48M shares derived: average of 3 quarters · filed 2017-06-07 | 80.84M shares derived: average of 4 quarters · filed 2017-06-07 | ||||
| 2015-03-31 | 80.95M shares 10-K · filed 2016-06-09 | 80.72M shares derived: average of 2 quarters · filed 2016-06-09 | 80.12M shares derived: average of 3 quarters · filed 2016-06-09 | 79.65M shares 10-K · filed 2017-06-07 | ||||
| 2014-12-31 | 80.49M shares 10-K · filed 2016-06-09 | 79.71M shares derived: average of 2 quarters · filed 2016-06-09 | 79.23M shares 10-Q · filed 2016-02-08 | 78.85M shares derived: average of 4 quarters · filed 2016-06-09 | ||||
| 2014-09-30 | 78.93M shares 10-K · filed 2016-06-09 | 78.59M shares 10-Q · filed 2015-11-09 | 78.30M shares derived: average of 3 quarters · filed 2016-06-09 | 78.04M shares derived: average of 4 quarters · filed 2016-06-09 | ||||
| 2014-06-30 | 78.24M shares 10-K · filed 2016-06-09 | 77.99M shares derived: average of 2 quarters · filed 2016-06-09 | 77.74M shares derived: average of 3 quarters · filed 2016-06-09 | 76.48M shares derived: average of 4 quarters · filed 2016-06-09 | ||||
| 2014-03-31 | 77.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | 77.49M shares derived: average of 2 quarters · filed 2016-06-09 | 75.90M shares derived: average of 3 quarters · filed 2016-06-09 | 73.14M shares 10-K · filed 2016-06-09 | ||||
| 2013-12-31 | 77.24M shares 10-Q · filed 2015-02-06 | 74.98M shares derived: average of 2 quarters · filed 2015-02-06 | 71.61M shares 10-Q · filed 2015-02-06 | 69.12M shares derived: average of 4 quarters · filed 2015-06-09 | ||||
| 2013-09-30 | 72.72M shares 10-Q · filed 2014-11-07 | 68.78M shares 10-Q · filed 2014-11-07 | 66.42M shares derived: average of 3 quarters · filed 2015-06-09 | 61.92M shares derived: average of 4 quarters · filed 2015-06-09 | ||||
| 2013-06-30 | 64.79M shares 10-Q · filed 2014-08-08 | 64.79B shares 10-Q · filed 2013-08-09 | 63.27M shares derived: average of 2 quarters · filed 2015-06-09 | 58.32M shares derived: average of 3 quarters · filed 2015-06-09 | ||||
| 2013-03-31 | 61.75M shares 10-K · filed 2015-06-09 | 55.09M shares derived: average of 2 quarters · filed 2015-06-09 | ||||||
| 2012-12-31 | 48.43M shares 10-Q · filed 2014-02-06 | 45.22M shares 10-Q · filed 2014-02-06 | 43.15M shares 10-K · filed 2015-06-09 | 43.15B shares 10-K · filed 2013-03-15 | ||||
| 2012-06-30 | 43.03B shares 10-Q · filed 2013-08-09 | 43.03M shares 10-Q · filed 2012-08-14 | 36.97M shares 10-Q · filed 2012-08-14 | |||||
| 2012-03-31 | 31.59M shares 10-K · filed 2015-06-09 | |||||||
| 2011-12-31 | 22.93M shares 10-K · filed 2014-06-10 | 22.93B shares 10-K · filed 2013-03-15 | ||||||
| 2011-06-30 | 11.55M shares 10-Q · filed 2012-08-14 | 11.18M shares 10-Q · filed 2012-08-14 | ||||||
| 2010-12-31 | 14.62M shares 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |